WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006114630) COMPOSITIONS FOR INTESTINAL CONDITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/114630    International Application No.:    PCT/GB2006/001538
Publication Date: 02.11.2006 International Filing Date: 26.04.2006
IPC:
A61K 31/4412 (2006.01), A61K 31/47 (2006.01), A61K 31/473 (2006.01), A61K 31/4745 (2006.01), A61K 31/498 (2006.01), A61K 31/519 (2006.01), A61K 31/522 (2006.01), A61P 1/00 (2006.01), A61P 31/06 (2006.01)
Applicants: AQ+PLC [GB/GB]; Stephen Mabbott Associates, 14 Mitchell Lane, Glasgow G1 3NU (GB) (For All Designated States Except US).
TAYLOR, Russell [GB/GB]; (GB) (For US Only)
Inventors: TAYLOR, Russell; (GB)
Agent: SZCZUKA, Jan, Tymoteusz; Marks & Clerk, 19 Royal Exchange Square, Glasgow G1 3AE (GB)
Priority Data:
0508412.4 26.04.2005 GB
Title (EN) COMPOSITIONS FOR INTESTINAL CONDITIONS
(FR) COMPOSITIONS POUR DES AFFECTIONS INTESTINALES
Abstract: front page image
(EN)Disclosed are uses of metal ion chelating compositions for the treatment or prophylaxis in humans or animals of inflammatory intestinal conditions such as those mediated by nano-bacterial infections such as MAP (Mycobacterium avium tuberculosis) infections. Preferably, the metal ion chelating agent is selected from the group consisting of 2, 3-dihydroxypyridine; 4 , 6-dihydroxypyrimidine ; 2-pteridinol ; 2 , 4-quinolindiol ; 2 , 3-dihydroxyguinoxalin; 2 , 4-pteridinediol ; 6-purinol; 3-phenanthridinol ; 2-phenanthrolinol; 2-phenazinilol; and 8-hydroxyquinoline .
(FR)Il est exposé des utilisations de compositions chélatant un ion métallique pour le traitement ou la prophylaxie chez des êtres humains ou des animaux d'affections intestinales inflammatoires telles que celles médiées par des infections mycobactériennes telles que des infections au MAP (Mycobacterium avium, sous-espèce paratuberculosis). De préférence, l'agent chélatant un ion métallique est sélectionné dans le groupe constitué des 2,3-dihydroxypyridine ; 4,6-dihydroxypyrimidine ; 2-ptéridinol ; 2,4-quinoléinediol ; 2,3-dihydroxyguinoxaline ; 2,4-ptéridinediol ; 6-purinol ; 3-phénanthridinol ; 2-phénanthrolinol ; 2-phénazinilol ; et 8-hydroxyquinoléine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)